A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma

BACKGROUND: The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC). METHODS: Histologically confirmed ACC patients with documented disease progression within 12 months prior to the study entry were eligible....

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dong-Wan, Oh, Do-Youn, Shin, Seong Hoon, Kang, Jin Hyoung, Cho, Byoung Chul, Chung, Joo-Seop, Kim, HyeJin, Park, Keon Uk, Kwon, Jung Hye, Han, Ji-Youn, Kim, Mi-Jung, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228069/
https://www.ncbi.nlm.nih.gov/pubmed/25362970
http://dx.doi.org/10.1186/1471-2407-14-795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228069/
https://www.ncbi.nlm.nih.gov/pubmed/25362970
http://dx.doi.org/10.1186/1471-2407-14-795

Ejemplares similares